ERBC (European Research Biology Center)
Maxime Chaton is an experienced financial professional currently serving as Head of Accounting & Consolidation at the European Research Biology Center since May 2023. Prior to this role, Maxime held the position of Senior Financial Auditor at EY from October 2018 to May 2023 and worked as a Management Controller in an apprenticeship at Groupe SII from September 2017 to September 2018. Maxime's early career includes positions such as Financial Administrative Assistant at CELAD and various roles at BNP Paribas. With a strong academic background from Toulouse School of Management and Université de Bordeaux, Maxime holds multiple degrees focusing on audit, finance, and management.
ERBC (European Research Biology Center)
Stemming from the merger of two reference CROs in pharmacology and toxicology (CERB and RTC), European Research Biology Center (ERBC) is a European leader in non-clinical studies. It offers to healthcare and chemical professionals a comprehensive range of experimental capabilities, preclinical models, regulatory pre-IND package and consultancy services to de-risk innovation and improve R&D productivity. Based in Baugy (France) and Roma (Italy), ERBC provides all services from preclinical proof-of-concept to market of any type of drug candidate or chemical compound. Each project is managed by a study director, relying on a multi-disciplinary team of experts, notably in general pharmacology, cardiology, electrophysiology and pathophysiology, also benefiting from a world class academic and private network. Every year, study reports from our two Centers are successfully used in support of market authorization and new product approval submissions around the world, including the European (EMA, ECHA), US (FDA and EPA) and Japanese (MHLW and MAFF) regulatory authorities. Investment in outstanding scientific and technical manpower, high-tech equipment and facilities are crucial cornerstones of our sound and organic growth. The quality and reliability of our performance is reflected by the many ongoing and long-lasting collaborations we maintain with leading international pharmaceutical and chemical companies. ERBC is deeply engaged in animal ethics and welfare. ERBC supports the Basel Declaration, respects the 3Rs concept and continually improves its tools and procedures to maximize the balance between the benefit for health and the animal well-being.